AVALYN PHARMACEUTICALS INC
Q3 2026 13F Holders
Symbol
AVLN
CUSIP
05348Y105
Type
Equity
Class
COM SHS
Num filings
15
Total reported value, excl. options
$27.6 M
Compare 2026 Q3 to
2026 Q2
Manager
Report Date
Value ($000)
Shares
Option Type